Dwight L Evans

Datos Biográficos

ID7119669
NOMBREDwight L Evans
NOMBRESDwight L
APELLIDOEvans
FIRMAEVANS D L
AFILIACIONESUniversity of Pennsylvania
VERIFICADONo
TOTAL DE OBRAS12
TOTAL DE CITAS0
TOTAL COMO AUTOR12
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN1983
AÑO MÁS RECIENTE DE PUBLICACIÓN2021
ÍNDICE H0

  • HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic

    Open AccessCécile Denis, Tiffany Dominique et al.ARTICLEAIDS and Behavior2021

  • HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana

    Open AccessPhilip R Opondo, Philip Opondo et al.ARTICLEAIDS and Behavior2017

  • Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and Replication

    Tami D Benton, Tami Benton et al.ARTICLEPsychosomatic Medicine2010

    OBJECTIVE: To test the hypothesis that the selective serotonin reuptake inhibitor (SSRI) citalopram would down-regulate human immunodeficiency virus (HIV) infectivity and that the greatest effects would be seen in people with depression. Depression is a risk factor for morbidity and mortality in HIV/acquired immune deficiency syndrome. Serotonin (5-HT) neurotransmission has been implicated in the pathobiology of depression, and pharmacologic ther…

  • Changes in Neuropsychological Functioning with Progression of HIV-1 Infection

    Open AccessTeri T Baldewicz, Jane Leserman et al.ARTICLEAIDS and Behavior2004

  • Progression to Aids, a clinical Aids condition and mortality

    Open AccessJane Leserman, John M Petitto et al.ARTICLEPsychological Medicine2002

    Background. The primary aim of this study is to examine prospectively the association of stressful life events, social support, depressive symptoms, anger, serum cortisol and lymphocyte subsets with changes in multiple measures of human immunodeficiency virus (HIV) disease progression. Methods. Ninety-six HIV-infected gay men without symptoms or anti-retroviral medication use at baseline were studied every 6 months for up to 9 years. Disease prog…

  • Depressive and Anxiety Disorders in Women With HIV Infection

    Mary F Morrison, John M Petitto et al.ARTICLEAmerican Journal of Psychiatry2002

    OBJECTIVE: This study examined whether there were differences in the rate of depressive and anxiety disorders between HIV-infected women (N=93) and a comparison group of uninfected women (N=62). Secondary objectives were to examine correlates of depression in HIV-infected women-including HIV disease stage and protease inhibitor use-and the associations between symptoms of depression or anxiety and other potential predictor variables. METHOD: Subj…

  • Impact of Stressful Life Events, Depression, Social Support, Coping, and Cortisol on Progression to Aids

    Jane Leserman, John M Petitto et al.ARTICLEAmerican Journal of Psychiatry2000

    OBJECTIVE: This study examined prospectively the effects of stressful events, depressive symptoms, social support, coping methods, and cortisol levels on progression of HIV-1 infection. METHOD: Eighty-two homosexual men with HIV type-1 infection without AIDS or symptoms at baseline were studied every 6 months for up to 7. 5 years. Men were recruited from rural and urban areas in North Carolina, and none was using antiretroviral medications at ent…

  • High Versus Low Basal Cortisol Secretion in Asymptomatic, Medication-free HIV-infected Men

    John M Petitto, Jane Leserman et al.ARTICLEBehavioral Medicine2000

    The authors hypothesized that HIV-infected men with high basal cortisol secretion would exhibit greater stress-related reductions in the ratio of Th1/Th2 cell-derived cytokines and numbers of CD8+ T and NK lymphocytes than low basal cortisol secretors. A semistructured interview was used to assess life stress during the preceding 6 months of 94 HIV-infected men classified as high and low cortisol secretors (n = 47/group). Increased levels of seve…

  • Progression to Aids

    Jane Leserman, Eric D Jackson et al.ARTICLEPsychosomatic Medicine1999

    OBJECTIVE: We examined the effects of stress, depressive symptoms, and social support on the progression of HIV infection. METHODS: Eighty-two HIV-infected gay men without symptoms or AIDS at baseline were followed up every 6 months for up to 5.5 years. Men were recruited from rural and urban areas in North Carolina as part of the Coping in Health and Illness Project. Disease progression was defined using criteria for AIDS (CD4+ lymphocyte count …

  • The Influence of Depressive Symptoms on Cognitive Difficulties Affecting Daily Living in Hiv-1 Infection

    S Silva, Teri T Baldewicz et al.ARTICLEPsychosomatic Medicine1998

    Silva, S.; Baldewicz, T.; Jackson, E.; Leserman, J.; Perkins, D.O.; Howe, L.; Evans, D.L.; Golden, R.N. Author Information

  • Treatment of depression in cancer patients is associated with better life adaptation

    Dwight L Evans, Cheryl F McCartney et al.ARTICLEPsychosomatic Medicine1988

    Major depression occurs in a significant number of cancer patients, and there is evidence that cancer patients with depression do not receive adequate antidepressant treatment. In an uncontrolled pilot study, the authors assess the degree of depression and the quality of life after the initiation of antidepressant medication treatment in 12 depressed cancer patients who received adequate antidepressant drugs and in 10 depressed cancer patients wh…

  • Floating” MMPI Profiles and DSM-III Diagnoses

    Open AccessCharles S Newmark, Pamela Chassin et al.ARTICLEPsychological Reports1983

    DSM-III diagnoses of 55 hospitalized psychiatric male patients who produced “floating” MMPI profiles were obtained via retrospective chart review. A prospective study of 16 then was conducted to cross-validate the initial diagnostic findings The results from both investigations suggested that at least half of these hospitalized psychiatric patients received a DSM-III diagnosis of either borderline personality disorder or major depressive disorder…